General Updates

August 26, 2026 BSE Limited Code: 532321 P J Towers, Dalal Street, Mumbai-400001 Na(cid:415)onal Stock Exchange of India Limited Code: Zyduslife Exchange Plaza, C/1, Block G, Bandra-Kurla Complex, Bandra (East), Mumbai-400051 Sub.: Incorpora(cid:415)on of a wholly owned subsidiary in Gi(cid:332) City, Gandhinagar, Gujarat Ref.: In(cid:415)ma(cid:415)on under regula(cid:415)on 30 of the SEBI (Lis(cid:415)ng Obliga(cid:415)ons and Disclosure Requirements) Regula(cid:415)ons, 2015 (“the Lis(cid:415)ng Regula(cid:415)ons”) read with SEBI Master Circular dated January 30, 2026 (“the SEBI Circular”) Dear Sir / Madam, This is to inform that a wholly owned subsidiary of Zydus Lifesciences Limited has been incorporated in the name of Zydus Global Treasury Centre IFSC Limited (“Gi(cid:332) City Company”) on August 25, 2026. Requisite details as required to be disclosed pursuant to the provisions of regula(cid:415)on 30 of the Lis(cid:415)ng Regula(cid:415)ons read with para A of part A of Schedule of the Lis(cid:415)ng Regula(cid:415)ons and para 1.1 of Annexure 18 of the SEBI Circular are provided in Annexure-“1”. Yours faithfully, For, Zydus Lifesciences Limited Dhaval N. Soni Company Secretary and Compliance Officer Membership No. FCS7063 Encl.: As above Annexure-“1” Sr. Par(cid:415)culars Responses 1. Name of the target en(cid:415)ty, details Name of the En(cid:415)ty: Zydus Global Treasury in brief such as size, turnover etc.: Centre IFSC Limited (“Gi(cid:332) City Company”) Authorized share capital: Rs. 5 Crores Paid-up share capital: Rs. 5 Crores Turnover: Nil (as Gi(cid:332) City Company is yet to commence business opera(cid:415)ons) 2. Whether the acquisi(cid:415)on would fall Since this is a newly incorporated company, it within related party transac(cid:415)on(s) is not a related party transac(cid:415)on. and whether the promoter/ promoter group/ group companies The Promoter / Promoter Group / Group have any interest in the en(cid:415)ty Companies are not interested in the said being acquired? If yes, nature of incorpora(cid:415)on. interest and details thereof and whether the same is done at Upon incorpora(cid:415)on as a wholly owned “arm’s length”: subsidiary of the Company, the Gi(cid:332) City Company has become a related party of the Company. 3. Industry to which the en(cid:415)ty being Treasury ac(cid:415)vi(cid:415)es and treasury services acquired belongs: 4. Objects and impact of acquisi(cid:415)on To undertake the business of Global and / or (including but not limited to, Regional Corporate Treasury Centre and to disclosure of reasons for carry out treasury ac(cid:415)vi(cid:415)es and treasury acquisi(cid:415)on of target en(cid:415)ty, if its services. business is outside the main line of business of the listed en(cid:415)ty): 5. Brief details of any governmental Not applicable as this in(cid:415)ma(cid:415)on is about a or regulatory approvals required newly incorporated wholly owned subsidiary. for the acquisi(cid:415)on: 6. Indica(cid:415)ve (cid:415)me period for Not applicable as this in(cid:415)ma(cid:415)on is about a comple(cid:415)on of the acquisi(cid:415)on: newly incorporated wholly owned subsidiary. 7. Considera(cid:415)on-whether cash 100% subscrip(cid:415)on to the paid-up share capital considera(cid:415)on or share swap or any of the Gi(cid:332) City Company is in cash. other form and details of the same: Sr. Par(cid:415)culars Responses 8. Cost of acquisi(cid:415)on and/or the Not applicable as this in(cid:415)ma(cid:415)on is about a price at which the shares are newly incorporated wholly owned subsidiary. acquired: 9. Percentage of shareholding / 100% (One Hundred percent) control acquired and / or number of shares acquired: 10. Brief background about the en(cid:415)ty Not applicable as this in(cid:415)ma(cid:415)on is about a acquired in terms of products/line newly incorporated wholly owned subsidiary. of business acquired, date of incorpora(cid:415)on, history of last 3 years turnover, country in which the acquired en(cid:415)ty has presence and any other significant informa(cid:415)on (in brief): For, Zydus Lifesciences Limited Dhaval N. Soni Company Secretary and Compliance Officer Membership No. FCS7063